Cargando…
Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
BACKGROUND: Without organized screening programs up to 60-70% of breast cancers are diagnosed at advanced stages that have significantly lower five-year survival rate and poorer outcomes, which is a serious global public health problem. The purpose of the blind clinical study was the assessment of t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189101/ https://www.ncbi.nlm.nih.gov/pubmed/37207139 http://dx.doi.org/10.3389/fonc.2023.1009863 |